enVVeno Medical's VenoValve shows sustained clinical benefits in three-year study data
NVNO•enVVeno Medical said patients with severe chronic venous insufficiency showed sustained, statistically significant improvements in disease severity, leg pain and quality of life in three-year VenoValve study results. The FDA authorized the enVVe pivotal trial in April 2026, with first-patient enrollment on track for year-end.




